NCT01726075 Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy Status COMPLETED Phase PHASE2/PHASE3
NCT01717937 Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging Status TERMINATED Phase N/A
NCT01694212 Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy Status COMPLETED Phase NA
NCT01692938 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO Status COMPLETED Phase N/A
NCT01628289 The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong Status COMPLETED Phase NA
NCT01625598 Computer Detection of Diabetic Retinopathy Compared to Clinical Examination Status COMPLETED Phase N/A
NCT01622816 Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart Status COMPLETED Phase N/A
NCT01591902 Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® Status TERMINATED Phase PHASE4
NCT01517490 Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes Status UNKNOWN Phase N/A
NCT01487629 Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema Status UNKNOWN Phase PHASE2
NCT01476449 Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema Status COMPLETED Phase PHASE2
NCT01445899 PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE2
NCT01440660 Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) Status COMPLETED Phase N/A
NCT01382498 Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy Status UNKNOWN Phase PHASE4
NCT01375166 Coupling of Neural Activity and Retinal Blood Flow in Diabetes Status TERMINATED Phase N/A